fraud

Federal investigators have searched the offices of Proove Biosciences, Stat News reports.

With data analytics and more specific billing codes, the government has improved its ability to identify medically unnecessary genetic testing and other fraudulent activity.

Give It Back

A major funding agency in China is cracking down on peer-review scams, ScienceInsider reports.

Experts believe that data in the single-molecule sequencing study published two years ago in Nature Nanotechnology was computer-generated.

The preliminary approval is the penultimate step to bringing to a close a class action lawsuit accusing Celera of making false and misleading statements about its finances.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investors are suing China Medical Technologies alleging the firm engaged in actions that artificially inflated its stock in violation of US securities law.

Signal filed its suit against Med BioGene earlier this month alleging a breach of agreement, violation of a confidentiality agreement, and misuse of proprietary information, among other charges.

In a document filed with the SEC, Sequenom said that Elizabeth Dragon has pled guilty to charges of making false statements about the company's prenatal test for Down syndrome and will be sentenced on Aug. 30.

Transgenomic has claimed in a suit that Power3 has wrongly terminated a licensing deal between the firms, while engaging in fraud and slander.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.